My Quote Request
No products added yet
6505-01-195-4569
20 Products
P&S LIQUID
SCALP TREATMENT,MEDICATED
NSN, MFG P/N
6505011954569
NSN
6505-01-195-4569
MFG
BAKER/CUMMINS PHARMACETICALS INC
Description
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,BAKER/CUMMINS,DERMATOLOGICALS DIV OF KEY PHARMACEUTICALS INC
PRIMARY CONTAINER CONTENT QUANTITY: 8.000 FLUID OUNCES
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: CONTAINS MINERAL OIL,GLYCERIN,PHENOL,SODIUM CHLORIDE,WATER AND FRAGRANCE; FOR TOPICAL USE
Related Searches:
NDC00054-8814-11
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011957525
NSN
6505-01-195-7525
NDC00054-8814-11
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011957525
NSN
6505-01-195-7525
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 GRAMS SODIUM POLYSTYRENE SULFONATE PER MILLILITER
ADMINISTRATION: ORAL OR RECTAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM POLYSTYRENE SULFONATE SUSPENSION 60ML BOTTLE 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, UNIT DOSE
SPECIAL FEATURES: EACH 60 ML CONTAINS 15 GRAMS SODIUM POLYSTYRENE SULFONATE,17-21.5 ML SORBITOL SOLUTION,0.2-0.3% ALCOHOL,AND 1.5 GRAMS (65 MEQ) SODIUM; A PALATABLE,FLAVORED SODIUM POLYSTYRENE SULFONATE SUSPENSION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC00054-8816-11
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011957525
NSN
6505-01-195-7525
NDC00054-8816-11
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011957525
NSN
6505-01-195-7525
MFG
BOEHRINGER INGELHEIM ROXANE INC. DIV SUB OF BOEHRINGER INGELHEIM CORP
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 GRAMS SODIUM POLYSTYRENE SULFONATE PER MILLILITER
ADMINISTRATION: ORAL OR RECTAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM POLYSTYRENE SULFONATE SUSPENSION 60ML BOTTLE 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, UNIT DOSE
SPECIAL FEATURES: EACH 60 ML CONTAINS 15 GRAMS SODIUM POLYSTYRENE SULFONATE,17-21.5 ML SORBITOL SOLUTION,0.2-0.3% ALCOHOL,AND 1.5 GRAMS (65 MEQ) SODIUM; A PALATABLE,FLAVORED SODIUM POLYSTYRENE SULFONATE SUSPENSION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
NDC46287-0006-60
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011957525
NSN
6505-01-195-7525
NDC46287-0006-60
SODIUM POLYSTYRENE SULFONATE SUSPENSION,USP
NSN, MFG P/N
6505011957525
NSN
6505-01-195-7525
MFG
CAROLINA MEDICAL PRODUCTS COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 GRAMS SODIUM POLYSTYRENE SULFONATE PER MILLILITER
ADMINISTRATION: ORAL OR RECTAL
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM POLYSTYRENE SULFONATE SUSPENSION 60ML BOTTLE 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 60.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, UNIT DOSE
SPECIAL FEATURES: EACH 60 ML CONTAINS 15 GRAMS SODIUM POLYSTYRENE SULFONATE,17-21.5 ML SORBITOL SOLUTION,0.2-0.3% ALCOHOL,AND 1.5 GRAMS (65 MEQ) SODIUM; A PALATABLE,FLAVORED SODIUM POLYSTYRENE SULFONATE SUSPENSION
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
012-123-002
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011960282
NSN
6505-01-196-0282
012-123-002
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011960282
NSN
6505-01-196-0282
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS ACETIC ACID PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 103.750 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 200.000 MILLIGRAMS DEXTROSE PER LITER AND 0.750 MEQ. MAGNESIUM ION PER LITER AND 100.000 MILLIEQUIVALENTS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 44 PARTS WATER; POTASSIUM IS NOT CONTAINED IN THIS SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: SODIUM LACTATE, ANHYDROUS PER LITER
Related Searches:
012123-004
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011960282
NSN
6505-01-196-0282
012123-004
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011960282
NSN
6505-01-196-0282
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS ACETIC ACID PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 103.750 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 200.000 MILLIGRAMS DEXTROSE PER LITER AND 0.750 MEQ. MAGNESIUM ION PER LITER AND 100.000 MILLIEQUIVALENTS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 44 PARTS WATER; POTASSIUM IS NOT CONTAINED IN THIS SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: SODIUM LACTATE, ANHYDROUS PER LITER
Related Searches:
RENALYTE RX 123
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011960282
NSN
6505-01-196-0282
RENALYTE RX 123
HEMODIALYSIS SOLUTION,CONCENTRATED
NSN, MFG P/N
6505011960282
NSN
6505-01-196-0282
MFG
COBE LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 MILLIGRAMS ACETIC ACID PER LITER AND 3.000 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 103.750 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 200.000 MILLIGRAMS DEXTROSE PER LITER AND 0.750 MEQ. MAGNESIUM ION PER LITER AND 100.000 MILLIEQUIVALENTS
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GALLONS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: STRENGTHS IN PAC AKJA ARE AFTER DILUTION OF 1 PART SOLUTION WITH 44 PARTS WATER; POTASSIUM IS NOT CONTAINED IN THIS SOLUTION
TOTAL PRIMARY CONTAINER QUANTITY: 4
~1: SODIUM LACTATE, ANHYDROUS PER LITER
Related Searches:
NDC00121-4577-35
LACTULOSE SOLUTION,USP
NSN, MFG P/N
6505011960612
NSN
6505-01-196-0612
NDC00121-4577-35
LACTULOSE SOLUTION,USP
NSN, MFG P/N
6505011960612
NSN
6505-01-196-0612
MFG
PHARMACEUTICAL MFRS ASSOCIATES
Description
ADMINISTRATION: ORAL OR RECTAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
FLAVOR: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LACTULOSE SOLUTION USP 30ML CUP 100S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 30.000 MILLILITERS
PRIMARY CONTAINER QUANTITY PER SECONDARY CONTAINER: 10 CUP, UNIT DOSE
PRIMARY CONTAINER TYPE: CUP, UNIT DOSE
SECONDARY CONTAINER TYPE: TRAY
SPECIAL FEATURES: 10 GRAMS LACTULOSE PER 15 ML
TOTAL PRIMARY CONTAINER QUANTITY: 10
TOTAL SECONDARY CONTAINER QUANTITY: 10
Related Searches:
2B0863
GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011961744
NSN
6505-01-196-1744
2B0863
GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011961744
NSN
6505-01-196-1744
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS GENTAMICIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION 100ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: PREMIXED IN 0.9% SODIUM CHLORIDE; NON-PYROGENIC; SINGLE DOSE 100 ML PLASTIC BAG WITH HANGER STRAP AND ONE PERMANENTLY ATTACHED OUTLET PORT
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
GENTAMICIN INJECTION PREMIXED
GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011961744
NSN
6505-01-196-1744
GENTAMICIN INJECTION PREMIXED
GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011961744
NSN
6505-01-196-1744
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS GENTAMICIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION 100ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: PREMIXED IN 0.9% SODIUM CHLORIDE; NON-PYROGENIC; SINGLE DOSE 100 ML PLASTIC BAG WITH HANGER STRAP AND ONE PERMANENTLY ATTACHED OUTLET PORT
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
NDC00338-0505-48
GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011961744
NSN
6505-01-196-1744
NDC00338-0505-48
GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION
NSN, MFG P/N
6505011961744
NSN
6505-01-196-1744
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS GENTAMICIN EQUIVALENT
ADMINISTRATION: INTRAVENOUS INFUSION
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION 100ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: PREMIXED IN 0.9% SODIUM CHLORIDE; NON-PYROGENIC; SINGLE DOSE 100 ML PLASTIC BAG WITH HANGER STRAP AND ONE PERMANENTLY ATTACHED OUTLET PORT
TOTAL PRIMARY CONTAINER QUANTITY: 24
Related Searches:
08-9004-6
SODIUM CHLORIDE,CAL
NSN, MFG P/N
6505011962120
NSN
6505-01-196-2120
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EACH LITER CONTAINS ACETATE ION 4 MEQ.,CALCIUM ION 3.5 MEQ.,CHLORIDE ION 104 MEQ.,MAGNESIUM ION 1.5 MEQ.,SODIUM ION 138 MEQ.,SODIUM BICARBONATE ION 39 MEQ.; AFTER DILUTION OF 1 PART ACID,1.83 PART DILUTED BICARBONATE AND 34 PARTS WATER. FOR USE WITH DRAKE
~1: WILLOCK 7000/7200/7300,GAMBRO AK-10,AND EXTRACORPOREAL SPS SYSTEMS
Related Searches:
9004
SODIUM CHLORIDE,CAL
NSN, MFG P/N
6505011962120
NSN
6505-01-196-2120
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EACH LITER CONTAINS ACETATE ION 4 MEQ.,CALCIUM ION 3.5 MEQ.,CHLORIDE ION 104 MEQ.,MAGNESIUM ION 1.5 MEQ.,SODIUM ION 138 MEQ.,SODIUM BICARBONATE ION 39 MEQ.; AFTER DILUTION OF 1 PART ACID,1.83 PART DILUTED BICARBONATE AND 34 PARTS WATER. FOR USE WITH DRAKE
~1: WILLOCK 7000/7200/7300,GAMBRO AK-10,AND EXTRACORPOREAL SPS SYSTEMS
Related Searches:
NATURALYTE
SODIUM CHLORIDE,CAL
NSN, MFG P/N
6505011962120
NSN
6505-01-196-2120
MFG
NATIONAL MEDICAL CARE MEDICAL PRODUCTS DIV INC DBA ERIKA INC
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: EACH LITER CONTAINS ACETATE ION 4 MEQ.,CALCIUM ION 3.5 MEQ.,CHLORIDE ION 104 MEQ.,MAGNESIUM ION 1.5 MEQ.,SODIUM ION 138 MEQ.,SODIUM BICARBONATE ION 39 MEQ.; AFTER DILUTION OF 1 PART ACID,1.83 PART DILUTED BICARBONATE AND 34 PARTS WATER. FOR USE WITH DRAKE
~1: WILLOCK 7000/7200/7300,GAMBRO AK-10,AND EXTRACORPOREAL SPS SYSTEMS
Related Searches:
NDC00615-0693-13
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505011962131
NSN
6505-01-196-2131
NDC00615-0693-13
MULTIVITAMIN AND MINERAL TABLETS
NSN, MFG P/N
6505011962131
NSN
6505-01-196-2131
MFG
MEDICAL TECHNOLOGIES SYSTEM INC VANGARD LABS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 INTERNATIONAL UNITS VITAMIN A ACTIVE INGREDIENT AND 5.000 MILLIGRAMS VITAMIN B12 ACTIVE INGREDIENT AND 4.000 MILLIGRAMS VITAMIN B6 ACTIVE INGREDIENT AND 400.000 INTERNATIONAL UNITS VITAMIN D ACTIVE INGREDIENT AND 15.000 INTERNATIONAL UNITS VITAMIN
ADMINISTRATION: ORAL
FEATURES PROVIDED: INDIVIDUALLY SEALED
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: VITAMIN B1 10.000 MG ACTIVE INGREDIENT AND VITAMIN B2 10.000 MG ACTIVE INGREDIENT AND VITAMIN B3 100.000 MG ACTIVE INGREDIENT AND VITAMIN B5 20.000 MG ACTIVE INGREDIENT
TOTAL PRIMARY CONTAINER QUANTITY: 100
~1: E ACTIVE INGREDIENT AND 12.000 MILLIGRAMS IRON ACTIVE INGREDIENT AND 150.000 MILLIEQUIVALENTS IODINE ACTIVE INGREDIENT AND 2.000 MILLIGRAMS COPPER ACTIVE INGREDIENT AND 65.000 MILLIGRAMS MAGNESIUM ACTIVE INGREDIENT AND 1.000 MILLIGRAMS MANGANESE ACTIVE
~2: INGREDIENT AND 1.000 MILLIGRAMS ZINC ACTIVE INGREDIENT
Related Searches:
NDC00378-1355-01
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
NDC00378-1355-01
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS TRIAMTERENE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00555-0444-02
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
NDC00555-0444-02
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
MFG
BARR PHARMACEUTICALS LLC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS TRIAMTERENE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-1008-01
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
NDC00781-1008-01
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
MFG
SANDOZ INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS TRIAMTERENE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00839-7422-06
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
NDC00839-7422-06
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
MFG
MOORE MEDICAL CORP MOORE H L DRUG EXCHANGE DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS TRIAMTERENE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC52544-0348-01
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
NDC52544-0348-01
TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS
NSN, MFG P/N
6505011965402
NSN
6505-01-196-5402
MFG
WATSON LABS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MILLIGRAMS TRIAMTERENE ACTIVE INGREDIENT AND 50.000 MILLIGRAMS HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLETS 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
